These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16180362)

  • 1. [The importance of nimodipine in treatment of dementia].
    Eckert A
    Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2000; 2002(2):CD000147. PubMed ID: 10796495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging, dementia and calcium metabolism.
    Kanowski S
    J Neural Transm Suppl; 1998; 54():195-200. PubMed ID: 9850928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of coexisting depression in patients with dementia: potential of calcium channel antagonists.
    De Vry J; Fritze J; Post RM
    Clin Neuropharmacol; 1997 Feb; 20(1):22-35. PubMed ID: 9037570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers and dementia.
    Nimmrich V; Eckert A
    Br J Pharmacol; 2013 Jul; 169(6):1203-10. PubMed ID: 23638877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
    Zongfang Z; Wenjing L; Zhaomin C; Lei Z
    Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
    Zhang JT
    Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects of acupuncture combined with nimodipine for treatment of vascular dementia in 30 cases.
    Zhong XY; Su XX; Liu J; Zhu GQ
    J Tradit Chin Med; 2009 Sep; 29(3):174-6. PubMed ID: 19894378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
    Pantoni L; Rossi R; Inzitari D; Bianchi C; Beneke M; Erkinjuntti T; Wallin A
    J Neurol Sci; 2000 Apr; 175(2):124-34. PubMed ID: 10831773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia.
    Yang Q; Liu J; Huang KL; Wang GY; Wang MY; Tan AH; Ran SM
    Medicine (Baltimore); 2022 Aug; 101(31):e29307. PubMed ID: 35945739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blocker nimodipine for primary degenerative dementia.
    Jarvik LF
    Biol Psychiatry; 1991 Dec; 30(11):1171-2. PubMed ID: 1777531
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Pharmacopsychiatry; 1996 Jul; 29(4):150-5. PubMed ID: 8858714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimodipine ameliorates trauma-induced cochlear neuronal death.
    Sekiya T; Yagihashi A; Asano K; Suzuki S
    Neurol Res; 2002 Dec; 24(8):775-80. PubMed ID: 12500700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
    Galgani S; Balestra P; Narciso P; Tozzi V; Sette P; Pau F; Visco G
    AIDS; 1997 Oct; 11(12):1520-1. PubMed ID: 9342076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.